KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Equity Ratio (2016 - 2025)

Johnson & Johnson's Equity Ratio history spans 17 years, with the latest figure at 0.41 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 3.12% year-over-year to 0.41; the TTM value through Dec 2025 reached 0.41, up 3.12%, while the annual FY2025 figure was 0.41, 3.12% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.41 at Johnson & Johnson, up from 0.41 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.43 in Q3 2022 and bottomed at 0.36 in Q2 2023.
  • The 5-year median for Equity Ratio is 0.4 (2025), against an average of 0.4.
  • The largest annual shift saw Equity Ratio decreased 13.67% in 2023 before it increased 12.59% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.39 in 2021, then grew by 8.65% to 0.43 in 2022, then decreased by 3.65% to 0.41 in 2023, then fell by 3.29% to 0.4 in 2024, then increased by 3.12% to 0.41 in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Equity Ratio are 0.41 (Q4 2025), 0.41 (Q2 2025), and 0.4 (Q1 2025).